NCT04044820 Opioid Use Post-Discharge After Ambulatory Distal Arm Surgery
| NCT ID | NCT04044820 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University Health Network, Toronto |
| Condition | Opioid Use |
| Study Type | INTERVENTIONAL |
| Enrollment | 292 participants |
| Start Date | 2019-03-04 |
| Primary Completion | 2026-12 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 292 participants in total. It began in 2019-03-04 with a primary completion date of 2026-12.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The aim of this study is to determine if a standardized evidence-based opioid prescription following elective hand and forearm surgery at Toronto Western Hospital (TWH) will decrease the number of unused opioid pills consumed by patients while still maintaining adequate pain control as compared to usual treatment. Currently, no standardized prescription exists at our institution.
Eligibility Criteria
Inclusion Criteria: 1\. Patients presenting to TWH for elective ambulatory hand and forearm surgery Exclusion Criteria: 1. Chronic opioid treatment, defined as more than 6 tablets of Oxycodone 5 mg per day (or equivalent) 2. Cognitive impairment or any other condition causing inability to use 'as required' medication for pain control 3. Language barrier preventing completion of patient diary 4. Patient refusal
Contact & Investigator
Anuj Bhatia, MD FRCPC
PRINCIPAL INVESTIGATOR
UHN
Frequently Asked Questions
Who can join the NCT04044820 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying Opioid Use. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04044820 currently recruiting?
Yes, NCT04044820 is actively recruiting participants. Contact the research team at anuj.bhatia@uhn.ca for enrollment information.
Where is the NCT04044820 trial being conducted?
This trial is being conducted at Toronto, Canada.
Who is sponsoring the NCT04044820 clinical trial?
NCT04044820 is sponsored by University Health Network, Toronto. The principal investigator is Anuj Bhatia, MD FRCPC at UHN. The trial plans to enroll 292 participants.